Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
- NCT ID
| Study title | Condition | Phase | Location | NCT ID |
|---|---|---|---|---|
Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN |
Glomerulonephritis, IGA, Immunoglobulin A Nephropathy | Phase2 | Argentina Israel Malaysia Saudi Arabia United States View all |
NCT06797518 |
Lipoprotein(a) Levels in Patients With Atherosclerotic Cardiovascular Diseases in Russia |
Atherosclerotic Cardiovascular Disease | Russia | NCT06858332 | |
An Extension Study for Patients Previously Enrolled in Studies With Pelabresib |
Hematologic Malignancy, Solid Tumor, Advanced Malignancies | Phase3 | Belgium Italy Netherlands United Kingdom United States View all |
NCT06401356 |
Home Reported Outcomes in C3G Study |
C3 Glomerulopathy | United States | NCT07029542 | |
Post Marketing Study on Pluvicto in Korea |
Metastatic Castration-resistant Prostate Cancer | South Korea | NCT06514521 | |
A Multi-center, Ambispective Cohort Study to Evaluate the Impact of Iptacopan for Adult Patients With PNH in China |
Paroxysmal Nocturnal Hemoglobinuria | China | NCT06931691 | |
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis |
Atopic Dermatitis | Phase2 | Argentina Canada China Czechia France Germany Italy Japan Netherlands Slovakia South Korea Spain Taiwan United States View all |
NCT06947993 |
Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension) |
Lupus Nephritis | Phase3 | Brazil China Colombia Czechia France Guatemala Hong Kong Hungary Malaysia Mexico Romania Singapore South Korea Spain Taiwan Thailand United States Vietnam View all |
NCT06711887 |
Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET |
Somatostatin Receptor Positive (SSTR+), Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) | Phase3 | Canada China France Germany Hungary Italy Netherlands Poland South Korea Spain United Kingdom United States View all |
NCT06784752 |
RWE,NIS,Prospective Study for the Effectiveness, Tolerability and Adherence of Asciminib in Saudi Arabia. (ASC4REAL) |
Chronic Myelogenous Leukemia in Chronic Phase | Saudi Arabia | NCT06684964 |